Literature DB >> 8388521

Cardiac morbidity and related mortality in children with HIV infection.

L M Luginbuhl1, E J Orav, K McIntosh, S E Lipshultz.   

Abstract

OBJECTIVE: Dysrhythmias, hemodynamic instability, congestive heart failure, and sudden death are serious complications of human immunodeficiency virus (HIV) infection that, to our knowledge, have not been studied systematically. We sought to determine the cumulative incidence and clinical predictors of these adverse events in a cohort of HIV-infected children.
DESIGN: Historical cohort study.
SETTING: University-affiliated, primary and tertiary care pediatric hospital and ambulatory care center. PARTICIPANTS: Eighty-one HIV-infected children who had one or more cardiac evaluations between 1984 and 1991 form the study cohort. The initial cardiac evaluation occurred at a median age of 1.5 years, and children were followed up to a median age of 3.6 years. MAIN OUTCOME MEASURES: Mortality (related to cardiac dysfunction as well as noncardiac causes), tachycardia, bradycardia, hypertension, hypotension, marked sinus arrhythmia, cardiac arrest, and chronic congestive heart failure.
RESULTS: Hemodynamic abnormalities and dysrhythmias occurred frequently. Eight unexpected cardiorespiratory arrests occurred in seven children (9%). Chronic congestive heart failure was noted in 10% of patients. Thirty children died, 10 with significant cardiac dysfunction. As HIV-infected children progressed from acquired immunodeficiency syndrome (AIDS)-related complex to AIDS, significant cardiac problems were more likely to occur. Both nonneurologic AIDS and encephalopathy were strongly associated with most severe cardiac outcomes. However, encephalopathy was the strongest correlate of cardiorespiratory arrest (P = .002). Epstein-Barr virus coinfection was the strongest correlate of chronic congestive heart failure (P < .001).
CONCLUSIONS: Cardiac morbidity and mortality are more common with advanced HIV infection. The presence of encephalopathy or Epstein-Barr virus coinfection identifies HIV-infected children at especially high risk for adverse cardiac outcomes.

Entities:  

Mesh:

Year:  1993        PMID: 8388521

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

1.  Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.

Authors:  H Jenson; K McIntosh; J Pitt; S Husak; M Tan; Y Bryson; K Easley; W Shearer
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

2.  Resolution of dilated cardiomyopathy in an adolescent with change of a failing highly active antiretroviral drug therapy.

Authors:  Twalib Olega Aliku; Sulaiman Lubega; Peter Lwabi
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

3.  Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Authors:  Steven E Lipshultz; William T Shearer; Bruce Thompson; Kenneth C Rich; Irene Cheng; E John Orav; Sulekha Kumar; Ricardo H Pignatelli; Louis I Bezold; Philip LaRussa; Thomas J Starc; Julie S Glickstein; Sharon O'Brien; Ellen R Cooper; James D Wilkinson; Tracie L Miller; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

4.  QTc interval prolongation in patients with HIV and AIDS.

Authors:  Mahmoud U Sani; Basil N Okeahialam
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

5.  Cardiac manifestations in HIV infected children.

Authors:  Pradeep Singh; Alok Hemal; Sheetal Agarwal; Dinesh Kumar
Journal:  Indian J Pediatr       Date:  2014-05-25       Impact factor: 1.967

6.  Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand.

Authors:  Prakul Chanthong; Keswadee Lapphra; Supawan Saihongthong; Sirintip Sricharoenchai; Orasri Wittawatmongkol; Wanatpreeya Phongsamart; Supattra Rungmaitree; Nantaka Kongstan; Kulkanya Chokephaibulkit
Journal:  AIDS       Date:  2014-09-10       Impact factor: 4.177

7.  Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study.

Authors:  C Langston; E R Cooper; J Goldfarb; K A Easley; S Husak; S Sunkle; T J Starc; A A Colin
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

8.  HIV-infected Children in Malawi Have Decreased Performance on the 6-minute Walk Test With Preserved Cardiac Mechanics Regardless of Antiretroviral Treatment Status.

Authors:  Amy E Sims Sanyahumbi; Mina C Hosseinipour; Danielle Guffey; Irving Hoffman; Peter N Kazembe; Madeline McCrary; Charles G Minard; Charles van der Horst; Craig A Sable
Journal:  Pediatr Infect Dis J       Date:  2017-07       Impact factor: 2.129

9.  Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study.

Authors:  Steven E Lipshultz; Kirk A Easley; E John Orav; Samuel Kaplan; Thomas J Starc; J Timothy Bricker; Wyman W Lai; Douglas S Moodie; George Sopko; Mark D Schluchter; Steven D Colan
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

10.  Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors:  W W Lai; S E Lipshultz; K A Easley; T J Starc; S E Drant; J T Bricker; S D Colan; D S Moodie; G Sopko; S Kaplan
Journal:  J Am Coll Cardiol       Date:  1998-11-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.